Lupin Share Price
Know More₹2,147.55-14.65 (-0.68%)
20-Dec-2024₹2,150.70-12.15 (-0.56%)
20-Dec-2024BSE : 500257
NSE : LUPIN
Sector : Health care
ISIN Code : INE326A01037
- BSE
- NSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: 20-Dec-2024
| Market Cap (₹ Cr) | 97,971 |
Traded Value (₹ Cr) | 3.74 |
Volume (Shares) | 17,426 |
Face Value (₹) | 2 |
52-Week High (₹) | 2,312.00 |
52-Week High Date | 05-Sep-2024 |
52-Week Low (₹) | 1,200.35 |
52-Week Low Date | 21-Dec-2023 |
All Time High (₹) | 2,312.00 |
All Time High Date | 05-Sep-2024 |
All Time Low (₹) | 0.80 |
All Time Low Date | 12-Apr-2001 |
Lupin Ltd
Lupin News
Lupin Announcement
Lupin Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 98,115 |
| EPS - TTM (₹) [C] | 57.57 |
| P/E Ratio (X) [C] | 37.36 |
| Face Value (₹) | 2 |
| Latest Dividend (%) | 400.00 |
| Latest Dividend Date | 16-Jul-2024 |
| Dividend Yield (%) | 0.37 |
| Book Value Share (₹) [C] | 342.87 |
| P/B Ratio (₹) [C] | 6.27 |
Funds Owning this Stock
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| HDFC Balanced Advantage Fund (IDCW) | 1187.64 | 57,91,252 | 1.24 |
| HDFC Balanced Advantage Fund (G) | 1187.64 | 57,91,252 | 1.24 |
| HDFC Top 100 Fund (IDCW) | 690.90 | 33,69,013 | 1.89 |
| HDFC Top 100 Fund (G) | 690.90 | 33,69,013 | 1.89 |
| Nippon India Pharma Fund (Bonus) | 656.99 | 32,03,676 | 7.61 |
| Nippon India Pharma Fund (IDCW) | 656.99 | 32,03,676 | 7.61 |
| Nippon India Pharma Fund - Direct (IDCW) | 656.99 | 32,03,676 | 7.61 |
| Nippon India Pharma Fund - Direct (G) | 656.99 | 32,03,676 | 7.61 |
| Nippon India Pharma Fund (G) | 656.99 | 32,03,676 | 7.61 |
| Nippon India Pharma Fund - Direct (Bonus) | 656.99 | 32,03,676 | 7.61 |
Load more
Research Reports
Stock Strength
| Today's Low/High (₹) | 2,138.40 2,177.75 |
| Week Low/High (₹) | 2,038.00 2,178.00 |
| Month Low/High (₹) | 1,986.00 2,178.00 |
| Year Low/High (₹) | 1,200.15 2,312.00 |
| All time Low/High (₹) | 0.80 2,312.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | 3.62% | 3.56% | -4.98 | -4.77% |
| 1 Month | 5.58% | 5.52% | 0.60 | 0.29% |
| 3 Month | -0.07% | -0.05% | -7.69 | -8.54% |
| 6 Month | 38.30% | 38.25% | 0.73 | 0.09% |
| 1 Year | 75.17% | 75.20% | 10.69 | 11.52% |
| 3 Year | 145.81% | 145.75% | 39.80 | 41.97% |
Company Info
Company Information
Chairman (Non-Executive) : M D Gupta
Managing Director : Nilesh Deshbandhu Gupta.
Director & Chief Executive Off : Vinita Gupta
Company Sec. & Compli. Officer : R V Satam
Independent Director : Jean-Luc Belingard
Executive Director & CFO : Ramesh Swaminathan
Independent Director : Mark D McDade
Independent Director : K B S Anand
Independent Director : Punita Kumar Sinha
Independent Director : Jeffrey Kindler
Independent Director : Alfonso Zulueta
Registered Office: Kalpataru Inspire 3rd Floor, Off Western Exp HW Santacruz-E,Mumbai,Maharashtra-400055 Ph: 91-22-6640 2323
FAQs about Lupin Ltd
1. What's the Lupin Ltd share price today?
Lupin Ltd share price was Rs 2,147.55 at close on 20th Dec 2024. Lupin Ltd share price was down by 0.68% from the previous closing price of Rs 2,162.20. Lupin Ltd share price trend:
- Last 1 Month: Lupin Ltd share price moved up by 5.58% on BSE
- Last 3 Months: Lupin Ltd share price moved down by 0.07% on BSE
- Last 12 Months: Lupin Ltd share price moved up by 75.17% on BSE
- Last 3 Years: Lupin Ltd price moved up by 145.81% on BSE
2. How can I quickly analyse the performance of the Lupin Ltd stock?
The performance of the Lupin Ltd stock can be quickly analysed on the following metrics:
- The stock's PE is 37.36
- Price to book value ratio is 6.27
- Dividend yield of 0.37
- The EPS (trailing 12 months) of the Lupin Ltd stock is Rs 57.57
3. What is the market cap of Lupin Ltd?
Lupin Ltd has a market capitalisation of Rs 97,971 crore.
4. What is Lupin Ltd's 52-week high/low share price?
The Lupin Ltd’s 52-week high share price is Rs 2,312.00 and 52-week low share price is Rs 1,200.35.
5. Is the Lupin Ltd profitable?
On a consolidated basis, Lupin Ltd reported a profit of Rs 807.76 crore on a total income of Rs 4,138.82 crore for the quarter ended 2024. For the year ended Sep 2024, Lupin Ltd had posted a profit of Rs 859.48 crore on a total income of Rs 5,715.02 crore.
6. Which are Lupin Ltd’s peers in the Health care sector?
Lupin Ltd’s top 5 peers in the Health care sector are Mankind Pharma, Dr Reddy's Labs, Zydus Lifesci., Lupin, Aurobindo Pharma, Alkem Lab, Abbott India.
7. Who owns how much in Lupin Ltd?
Key changes to the Lupin Ltd shareholding are as follows:
- Promoter holding in Lupin Ltd has gone down to 46.96 per cent as of Sep 2024 from 47.04 per cent as of Dec 2023.
